Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 10, 2003, Pages 1023-1029

  Romero Gomez M ^a   Martinez Delgado C ^b   Hergueta, P ^c   Navarro, J M ^d   Garrido Serrano, A ^e   Santos, O ^b   Montojo, C ^b  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b Hospital Alarcos   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^d HOSPITAL COSTA DEL SOL   (Spain)

^e Hospital Rio Tinto   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; CLAVULANIC ACID; CREATININE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; BACTERIURIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSGEUSIA; ERADICATION THERAPY; FEMALE; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT; PEPTIC ULCER; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; STOMACH BIOPSY; THROMBOCYTOPENIA; UREA BREATH TEST;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; CLAVULANIC ACIDS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER HEMORRHAGE; RECURRENCE; STOMACH ULCER; TREATMENT FAILURE;

EID: 0345688976     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01763.x     Document Type: Article

References (27)

1. Miño Fungarolas G, Jaramillo JL, Galvez Calderon C, Carmona Ibañez C, Reyes López A, De la Mata M. Análisis de una serie general prospectiva de 3270 hemorragias digestivas altas. Rev Esp Enf Digest 1992; 82: 7-15.
2. Czernichow P, Hochain P, Nousbaum JB, et al. Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol 2000; 12: 175-81.
3. Chinn A, Weckesser EC. Acute hemorrhage from peptic ulceration. An Analysis of 322 Cases. Ann Intern Med 1951: 339-42.
4. Romero Gomez M, Vargas J, Utrilla D, et al. Estudio prospectivo sobre la influencia de la hemorragia ulcerosa en los métodos diagnósticos de infección por H. pylori. Gastroenterol Hepatol 1998; 19: 234-9.
5. Veenendaal RA, Peña S, Meijer JL, et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991; 32: 1291-4.
6. Sharma VK, Sahai AV, Corder FA, Howden CW. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther 2001; 15: 1939-47.
7. Labenz J, Börsch G. Role of H. pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
8. Rokkas T, Karamaris A, Mavrogeorgis A. Eradication of H. pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastroeintest Endosc 1995; 41: 1-4.
9. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343: 310-6.
10. Sheu BS, Chi CH, Huang CC, Kao AW, Wang YL, Yang HB. Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding. Aliment Pharmacol Ther 2002; 16: 137-43.
11. Cutler AF, Schubert TT. Patients factors affecting H. pylori erradication with triple therapy. Am J Gastroenterol 1993; 88: 505-9.
12. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomised comparison of quadruple and triple therapies for Helicobacter pylori eradication. The QUADRATE Study. Gastroenterol 2002; 123: 1763-9.
13. Romero Gómez M, Martinez Delgado C, Grande L, Otero Fernandez MA, Vargas J, Castro Fernandez M. Intravenous eradication therapy for bleeding gastroduodenal ulcer associated with Helicobacter pylori infection. Rev Esp Enferm Dig 2000; 92: 386-91.
14. Foster DN, Miloszewski KJ, Losowsky MS. Stigmata of recent hemorrhage in diagnosis and prognosis of upper gastrointestinal bleeding. Br Med J 1978; 6121: 1173-7.
15. Logan RP. Urea breath test in the management of Helicobacter pylori infection. Gut 1998; 43: S47-S50.
16. Eisenhart C. Inverse sine transformation of proportions. In: Eisenhart, C. Hastay, MW. Vallis, WA. eds. Selected Techniques of Statistical Analysis. New York: McGraw-Hill, 1947: 395-416.
17. Ruiz Gomez FA, Sanchez Serrano FJ, Martinez Egea A, Garcia Del Castillo G, Sanchez Cuenca J, Coronas Planas M. Intravenous 3-day Helicobacter pylori eradication therapy is highly effective in patients with bleeding peptic ulcer. Gastroenterol Hepatol 2002; 25: 383-6.
18. Pollak PT. A liquid chromatography assay for the study of serum and gastric juice metronidazole concentrations in the treatment of Helicobacter pylori. Ther Drug Monit 1996; 18: 678-87.
19. Catalano F, Branciforte G, Catanzaro R, Cipolla R, Bentivegna C, Brogna A. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen. Aliment Pharmacol Ther 2000; 14: 1329-34.
20. de Boer WA, van Etten RJ, Schade RW, Ouwehand ME, Schneeberger PM, Tytgat GN. 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection. Am J Gastroenterol 1996; 91: 1778-82.
21. Grimley CE, Penny A, O'sullivan M, et al. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. Aliment Pharmacol Ther 1999; 13: 869-73.
22. Van Zanten SJ, Goldie J, Hollingsworth J, Silletti C, Richardson H, Hunt RH. Secretion of intravenous administered antibiotics in gastric juice: implications for management of Helicobacter pylori. J Clin Pathol 1992; 45: 225-7.
23. Ortiz RA, Calafatti SA, Corazzi A, et al. Amoxicillin and ampicillin are not transferred to gastric juice irrespective of Helicobacter pylori status or acid blockade by omeprazole. Aliment Pharmacol Ther 2002; 16: 1163-70.
24. Sung JJ, Chung SC, Hosking SW, et al. Mucosal pharmacokinetics and pilot study of short course of parenteral imipenem in the eradication of Helicobacter pylori. J Gastroenterol Hepatol 1995; 10: 66-9.
25. Adamek RJ, Opferkuch W, Wegener M. Short-term omeprazole oral/ amoxicillin intravenous therapy for Helicobacter pylori eradication. A lack of therapeutic effect. Am J Gastroenterol 1994; 89: 1602-3.
26. Adamek RJ, Wegener M, Labenz J, Freitag M, Opferkuch W, Röld GH. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Asm J Gastroenterol 1994; 89: 39-42.
27. Adamek RJ, Wegener M. Combined intravenous and oral omeprazole/ amoxicillin therapy in patients with Helicobacter pylori-positive acute peptic ulcer bleeding. Am J Gastroenterol 1993; 88: 1980.